3-Hydroxy-5-methyl-2-hexanone
Common Name: |
3-Hydroxy-5-methyl-2-hexanone |
IUPAC Name: |
3-hydroxy-5-methylhexan-2-one |
Molecular Formula: |
C7H10O3 |
SMILES: |
CC(C)CC(C(=O)C)O |
Inchi: |
1S/C7H14O2/c1-5(2)4-7(9)6(3)8/h5,7,9H,4H2,1-3H3 |
Inchi Key: |
LZDPYURTPRCDJG-UHFFFAOYSA-N |
Cas No: |
163038-04-8 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
2 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
142.15 |
Mass (g/mol) |
130.099 |
Molar Refractivity |
35.55 |
Net Charge |
|
HBD |
|
HBA |
3 |
Rt Bonds |
1 |
Rings |
|
TPSA |
35.53 |
Hetero Atoms |
2 |
Heavy Atoms |
10 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
39.00 to 41.00 @ 0.06 mm Hg |
Vapor Pressure (mmHg@25.00 °C) |
0.426 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.57 |
LogP |
0.982 |
iLOGP |
2.07 |
XLOGP3 |
1.01 |
WLOGP |
0.85 |
MLOGP |
-0.57 |
ESOL Log S |
-1.29 |
ESOL Solubility (mg/ml) |
7.26 |
ESOL Solubility (mol/l) |
0.051 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-1.35 |
Ali Solubility (mg/ml) |
6.42 |
Ali Solubility (mol/l) |
0.05 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
-1.24 |
Silicos-IT Solubility (mg/ml) |
8.27 |
Silicos-IT Solubility (mol/l) |
0.06 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.45 |
Bioavailability Score |
0.85 |
Caco2 |
0 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.667 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.638 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |